Emergent BioSolutions Inc - Company Profile
Powered by
All the data and insights you need on Emergent BioSolutions Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Emergent BioSolutions Inc Strategy Report
- Understand Emergent BioSolutions Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Emergent BioSolutions Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022187361A1 | Application | VALIOLAMINE DERIVATIVES AS GLUCOSIDASE INHIBITORS | September 09, 2022 | |
EP4048306A1 | Application | CHIKUNGUNYA-VIRUS-ÄHNLICHER PARTIKELIMPFSTOFF UND VERFAHREN ZU SEINER VERWENDUNG | A61K2039/5258; A61K2039/545; A61K2039/55505; A61K39/12; A61P31/12; A61P31/14; C07K14/005; C12N2770/36123; C12N2770/36134; C12N2770/36171; Y02A50/30 | August 31, 2022 |
WO2022177990A2 | Application | MODIFIED SARS-COV-2 SPIKE POLYPEPTIDES AND NANOPARTICLES THEREOF | August 25, 2022 | |
USD0957624S | Grant | Autoinjector | July 12, 2022 | |
KR1020220097422A | Application | 치쿤구니야 바이러스 유사 입자 백신 및 이의 사용 방법 | A61K2039/5258; A61K2039/545; A61K2039/55505; A61K39/12; A61P31/12; A61P31/14; C07K14/005; C12N2770/36123; C12N2770/36134; C12N2770/36171; Y02A50/30 | July 07, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer